HLA-G and neoplasm: In addition, increased presentation of HLA-G on tumor cells results in the failure of NK cell-based immunotherapy,20 26 which may explain why Dox-treated HLA-G knockdown MDA-MB-231 cells were more sensitive to mock control NK-induced cytotoxic killing.